Wealth Enhancement Trust Services’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
Wealth Enhancement Trust Services's SMMT Position: Q3 2026 in Review
Wealth Enhancement Trust Services sold out of Summit Therapeutics (SMMT) in Q3 2026, closing a stake of 81 shares — an estimated $1.18K sold.
Wealth Enhancement Trust Services first reported a position in SMMT in Q1 2026 and held it in 2 quarters. The position peaked at $1.54K in Q1 2026. 295 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- Wealth Enhancement Trust Services reported no remaining Summit Therapeutics position as of Q3 2026 after selling out during the quarter.
- Wealth Enhancement Trust Services sold 81 Summit Therapeutics shares in Q3 2026, an estimated $1.18K.
- Wealth Enhancement Trust Services first reported a position in Summit Therapeutics in Q1 2026 and held it in 2 quarters.
- Wealth Enhancement Trust Services's Summit Therapeutics position peaked at $1.54K in Q1 2026.
- 295 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.